No abstract available
MeSH terms
-
Adenocarcinoma / genetics*
-
Adenocarcinoma / secondary
-
Adenocarcinoma / therapy
-
Adenocarcinoma, Papillary / genetics*
-
Adenocarcinoma, Papillary / therapy
-
Adult
-
Aged
-
Antineoplastic Agents / therapeutic use
-
Child
-
DNA Mutational Analysis
-
Drug Resistance, Neoplasm
-
ErbB Receptors / antagonists & inhibitors
-
ErbB Receptors / genetics*
-
Fatal Outcome
-
Female
-
Genetic Predisposition to Disease
-
Germ-Line Mutation*
-
Heredity
-
Humans
-
Lung Neoplasms / genetics*
-
Lung Neoplasms / pathology
-
Lung Neoplasms / therapy
-
Male
-
Middle Aged
-
Neoplasm Invasiveness
-
Neoplasm Staging
-
Pedigree
-
Phenotype
-
Pneumonectomy
-
Protein Kinase Inhibitors / therapeutic use
-
Treatment Failure
Substances
-
Antineoplastic Agents
-
Protein Kinase Inhibitors
-
EGFR protein, human
-
ErbB Receptors